Filing Details
- Accession Number:
- 0001209191-16-095084
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-02-02 21:11:43
- Reporting Period:
- 2016-01-29
- Filing Date:
- 2016-02-02
- Accepted Time:
- 2016-02-02 21:11:43
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1326732 | Xencor Inc | XNCR | Pharmaceutical Preparations (2834) | 201622502 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1218981 | Iii S John Stafford | 350 N. Orleans, 2N Chicago IL 60654 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-01-29 | 25 | $10.83 | 25 | No | 4 | P | Indirect | By Limited Liability Company |
Common Stock | Disposition | 2016-02-01 | 25 | $10.79 | 0 | No | 4 | S | Indirect | By Limited Liability Company |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By Limited Liability Company |
No | 4 | S | Indirect | By Limited Liability Company |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 5,264,740 | Direct |
Footnotes
- The Reporting Person's purchase of the Issuer's common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 25 shares, with the Reporting Person's sale of 30,000 shares of the Issuer's common stock at a weighted average price of $15.1302 per share on December 3, 2015. The Reporting Person has agreed to pay to the Issuer, upon settlement of the purchase, $107.50, representing the full amount of the profit realized in connection with the short-swing transaction, less transaction costs.
- These securities are held of record by Ronin Capital, LLC, a limited liability company owned and managed by the Reporting Person. The Reporting Person is the indirect beneficial owner of all the shares of common stock of Xencor, Inc. held of record by Ronin Capital, LLC.